Insomnia in Chronic Kidney Disease
Conditions
Interventions
CKD insomnia patients:None
CKD patients without insomnia:None
Sponsors
Hangzhou Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Exposure Group (CKD Insomnia Group): 1) Meets KDIGO 2024 Guidelines diagnostic criteria for CKD Stages 3-5; 2) Meets International Classification of Sleep Disorders-3 (ICSD-3) diagnostic criteria for chronic insomnia (duration =3 months, PSQI =7 points); 3) Age 18–75 years, no gender restrictions; 4) Voluntarily signed informed consent. (2) Control Group (Non-CKD Insomnia Group): 1) Meets KDIGO 2024 Guidelines diagnostic criteria for CKD stages 3–5; 2) Age 18–75 years, no gender restrictions; 3) Voluntarily signed informed consent.
Exclusion criteria
Exclusion criteria: (1) End-stage renal disease patients undergoing dialysis; (2) Secondary insomnia (e.g., severe depression, sleep apnea, medication-induced insomnia); (3) Severe comorbidities (NYHA Class III-IV heart failure, advanced cancer, dementia); (4) Individuals who have received acupuncture or meridian intervention therapy within the past month; (5) Pregnant or lactating women; (6) Patients with severe neuropsychiatric disorders; (7) Individuals with a history of limb surgery; (8) Patients with infectious diseases or skin lesions in the meridian examination area.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Grading of Meridian Acupoint Tenderness;Meridian Detection Device Results;Documentation of Meridian Abnormalities, ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep Assessment; | — |
Countries
China
Contacts
Public Contactzhoujie
Hangzhou Hospital of Traditional Chinese Medicine
Outcome results
None listed